Global Anticancer Drugs Market Research Report 2021

1 Anticancer Drugs Market Overview

• 1.1 Product Overview and Scope of Anticancer Drugs
• 1.2 Anticancer Drugs Segment by Type
  • 1.2.1 Global Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
  • 1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
  • 1.2.4 Hormonal Drugs
• 1.3 Anticancer Drugs Segment by Application
  • 1.3.1 Anticancer Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Lung Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Leukemia
  • 1.3.5 Colorectal Cancer
  • 1.3.6 Other
• 1.4 Global Anticancer Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Anticancer Drugs Revenue 2016-2027
  • 1.4.2 Global Anticancer Drugs Sales 2016-2027
  • 1.4.3 Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anticancer Drugs Market Competition by Manufacturers

• 2.1 Global Anticancer Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Anticancer Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Anticancer Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Anticancer Drugs Market Competitive Situation and Trends
  • 2.5.1 Anticancer Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Anticancer Drugs Players Market Share by Revenue
  • 2.5.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anticancer Drugs Retrospective Market Scenario by Region

• 3.1 Global Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Anticancer Drugs Market Facts & Figures by Country
  • 3.3.1 North America Anticancer Drugs Sales by Country
  • 3.3.2 North America Anticancer Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Anticancer Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Anticancer Drugs Sales by Country
  • 3.4.2 Europe Anticancer Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Anticancer Drugs Sales by Region
  • 3.5.2 Asia Pacific Anticancer Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Anticancer Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Anticancer Drugs Sales by Country
  • 3.6.2 Latin America Anticancer Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Anticancer Drugs Sales by Country
  • 3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Anticancer Drugs Historic Market Analysis by Type

• 4.1 Global Anticancer Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Anticancer Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Anticancer Drugs Price by Type (2016-2021)

5 Global Anticancer Drugs Historic Market Analysis by Application

• 5.1 Global Anticancer Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Anticancer Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Anticancer Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 F. Hoffmann-La Roche Ltd
  • 6.1.1 F. Hoffmann-La Roche Ltd Corporation Information
  • 6.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
  • 6.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 F. Hoffmann-La Roche Ltd Product Portfolio
  • 6.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
• 6.2 Eli Lilly and Company
  • 6.2.1 Eli Lilly and Company Corporation Information
  • 6.2.2 Eli Lilly and Company Description and Business Overview
  • 6.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Eli Lilly and Company Product Portfolio
  • 6.2.5 Eli Lilly and Company Recent Developments/Updates
• 6.3 CELGENE CORPORATION
  • 6.3.1 CELGENE CORPORATION Corporation Information
  • 6.3.2 CELGENE CORPORATION Description and Business Overview
  • 6.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 CELGENE CORPORATION Product Portfolio
  • 6.3.5 CELGENE CORPORATION Recent Developments/Updates
• 6.4 Novartis AG
  • 6.4.1 Novartis AG Corporation Information
  • 6.4.2 Novartis AG Description and Business Overview
  • 6.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Novartis AG Product Portfolio
  • 6.4.5 Novartis AG Recent Developments/Updates
• 6.5 Pfizer Inc
  • 6.5.1 Pfizer Inc Corporation Information
  • 6.5.2 Pfizer Inc Description and Business Overview
  • 6.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Pfizer Inc Product Portfolio
  • 6.5.5 Pfizer Inc Recent Developments/Updates
• 6.6 Amgen Inc
  • 6.6.1 Amgen Inc Corporation Information
  • 6.6.2 Amgen Inc Description and Business Overview
  • 6.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Amgen Inc Product Portfolio
  • 6.6.5 Amgen Inc Recent Developments/Updates
• 6.7 Bayer AG
  • 6.6.1 Bayer AG Corporation Information
  • 6.6.2 Bayer AG Description and Business Overview
  • 6.6.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bayer AG Product Portfolio
  • 6.7.5 Bayer AG Recent Developments/Updates
• 6.8 AstraZeneca
  • 6.8.1 AstraZeneca Corporation Information
  • 6.8.2 AstraZeneca Description and Business Overview
  • 6.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 AstraZeneca Product Portfolio
  • 6.8.5 AstraZeneca Recent Developments/Updates
• 6.9 Takeda Pharmaceutical Company Limited
  • 6.9.1 Takeda Pharmaceutical Company Limited Corporation Information
  • 6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
  • 6.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Takeda Pharmaceutical Company Limited Product Portfolio
  • 6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
• 6.10 Merck & Co.
  • 6.10.1 Merck & Co. Corporation Information
  • 6.10.2 Merck & Co. Description and Business Overview
  • 6.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Merck & Co. Product Portfolio
  • 6.10.5 Merck & Co. Recent Developments/Updates

7 Anticancer Drugs Manufacturing Cost Analysis

• 7.1 Anticancer Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Anticancer Drugs
• 7.4 Anticancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Anticancer Drugs Distributors List
• 8.3 Anticancer Drugs Customers

9 Anticancer Drugs Market Dynamics

• 9.1 Anticancer Drugs Industry Trends
• 9.2 Anticancer Drugs Growth Drivers
• 9.3 Anticancer Drugs Market Challenges
• 9.4 Anticancer Drugs Market Restraints

10 Global Market Forecast

• 10.1 Anticancer Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Anticancer Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Anticancer Drugs by Type (2022-2027)
• 10.2 Anticancer Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Anticancer Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Anticancer Drugs by Application (2022-2027)
• 10.3 Anticancer Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Anticancer Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Anticancer Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List